{"doi":"10.1021\/cg800035w","coreId":"137054","oai":"oai:bradscholars.brad.ac.uk:10454\/4846","identifiers":["oai:bradscholars.brad.ac.uk:10454\/4846","10.1021\/cg800035w"],"title":"Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients.","authors":["Berry, David J.","Seaton, Colin C.","Clegg, W.","Harrington, R. W.","Coles, S. J.","Horton, P. N.","Hursthouse, M. B.","Storey, R.","Jones, W.","Fris\u00bfc\u00bfic\u00b4, T.","Blagden, Nicholas"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2008-05","abstract":"noCo-crystal screening is routinely undertaken using high-throughput solution growth. We report a low- to medium throughput\\ud\napproach, encompassing both a melt and solution crystallization step as a route to the identification of co-crystals. Prior\\ud\nto solution studies, a melt growth step was included utilizing the Kofler mixed fusion method. This method allowed elucidation of\\ud\nthe thermodynamic landscape within the binary phase diagram and was found to increase overall screening efficiency. The\\ud\npharmaceutically acceptable adduct nicotinamide was selected and screened against a small set of active pharmaceutical ingredients\\ud\n(APIs) (ibuprofen (both the racemic compound (R\/S) and S-enantiomer), fenbufen, flurbiprofen (R\/S), ketoprofen (R\/S), paracetamol,\\ud\npiracetam, and salicylic acid) as part of a larger systematic study of synthon stability. From the screen, three new co-crystal systems\\ud\nhave been identified (ibuprofen (R\/S and S) and salicylic acid) and their crystal structures determined. Because of poor crystal\\ud\ngrowth synchrotron radiation was required for structure solution of the S-ibuprofen nicotinamide co-crystal. Two further potential\\ud\nsystems have also been discovered (fenbufen and flurbiprofen), but crystals suitable for structure determination have yet to be\\ud\nobtained. A greater ability to control crystallization kinetics is required to yield phase-pure single-crystalline material for full verification\\ud\nof this crystal engineering strategy","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":null,"rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/4846<\/identifier><datestamp>\n                2014-05-19T14:20:42Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nApplying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients.<\/dc:title><dc:creator>\nBerry, David J.<\/dc:creator><dc:creator>\nSeaton, Colin C.<\/dc:creator><dc:creator>\nClegg, W.<\/dc:creator><dc:creator>\nHarrington, R. W.<\/dc:creator><dc:creator>\nColes, S. J.<\/dc:creator><dc:creator>\nHorton, P. N.<\/dc:creator><dc:creator>\nHursthouse, M. B.<\/dc:creator><dc:creator>\nStorey, R.<\/dc:creator><dc:creator>\nJones, W.<\/dc:creator><dc:creator>\nFris\u00bfc\u00bfic\u00b4, T.<\/dc:creator><dc:creator>\nBlagden, Nicholas<\/dc:creator><dc:subject>\nCo-crystal screening<\/dc:subject><dc:subject>\nSolution crystallization<\/dc:subject><dc:subject>\nMelt crystallization<\/dc:subject><dc:subject>\nCrystal engineering<\/dc:subject><dc:subject>\nNicotinamide<\/dc:subject><dc:description>\nno<\/dc:description><dc:description>\nCo-crystal screening is routinely undertaken using high-throughput solution growth. We report a low- to medium throughput\\ud\napproach, encompassing both a melt and solution crystallization step as a route to the identification of co-crystals. Prior\\ud\nto solution studies, a melt growth step was included utilizing the Kofler mixed fusion method. This method allowed elucidation of\\ud\nthe thermodynamic landscape within the binary phase diagram and was found to increase overall screening efficiency. The\\ud\npharmaceutically acceptable adduct nicotinamide was selected and screened against a small set of active pharmaceutical ingredients\\ud\n(APIs) (ibuprofen (both the racemic compound (R\/S) and S-enantiomer), fenbufen, flurbiprofen (R\/S), ketoprofen (R\/S), paracetamol,\\ud\npiracetam, and salicylic acid) as part of a larger systematic study of synthon stability. From the screen, three new co-crystal systems\\ud\nhave been identified (ibuprofen (R\/S and S) and salicylic acid) and their crystal structures determined. Because of poor crystal\\ud\ngrowth synchrotron radiation was required for structure solution of the S-ibuprofen nicotinamide co-crystal. Two further potential\\ud\nsystems have also been discovered (fenbufen and flurbiprofen), but crystals suitable for structure determination have yet to be\\ud\nobtained. A greater ability to control crystallization kinetics is required to yield phase-pure single-crystalline material for full verification\\ud\nof this crystal engineering strategy.<\/dc:description><dc:date>\n2011-03-22T16:27:33Z<\/dc:date><dc:date>\n2011-03-22T16:27:33Z<\/dc:date><dc:date>\n2008-05<\/dc:date><dc:type>\nArticle<\/dc:type><dc:identifier>\nBerry, D. J., Seaton, C. C., Clegg, W., Harrington, R. W., Coles, S. J., Horton, P. N., Hursthouse, M. B., Storey, R., Jones, W., Fris\u00bfc\u00bfic\u00b4, T. and Blagden, N. (2008). Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients. Crystal growth & design, Vol. 8, No. 5, pp. 1697-1712.<\/dc:identifier><dc:identifier>\n90004827<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/4846<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1021\/cg800035w<\/dc:relation>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1021\/cg800035w"],"year":2008,"topics":["Co-crystal screening","Solution crystallization","Melt crystallization","Crystal engineering","Nicotinamide"],"subject":["Article"],"fullText":null}